ReviewJournal of medical case reports2023
Dermatofibrosarcoma protuberans challenges: a case series and review of the literature.
Review in Journal of medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 11 citations in OpenAlex.
- Unusual presentation of dermatofibrosarcoma protuberans in a young female: a rare case report and literature review.Annals of medicine and surgery (2012) · 2026Article
- Dermatofibrosarcoma protuberans mimicking hemorrhoids: a rare case report.International journal of surgery case reports · 2026Article
- Unusual presentation of dermatofibrosarcoma protuberans of the thigh: a case report.Annals of medicine and surgery (2012) · 2025Article
- Fifth-Time Recurrence of Dermatofibrosarcoma Protuberans at Distinct Sites: A Rare Case Report.Clinical case reports · 2025Article
- [Dermatofibrosarcoma protuberans treated with Mohs surgery]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2025Article
- Rare case of massive inguinal dermatofibrosarcoma protuberans: A case report.Clinical case reports · 2024Article
- Dermatofibrosarcoma protuberans: Case series in a tropical setting and review of literature.Rare tumors · 2024Article
- Dermatofibrosarcoma protuberans in a pre-adolescent child.International journal of surgery case reports · 2023Article
- A case of dermatofibrosarcoma protuberance with myoid differentiation - A rare occurrence.Journal of oral and maxillofacial pathology : JOMFPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDermatofibrosarcoma protuberans (DFSP) is a rare variant of skin sarcoma which is characterized by proliferation of spindle cells in a storiform pattern. Although it is mostly benign in its primary stages, it can cause a high burden of morbidity unless it is thoroughly excised. CASE PRESENTATION: Here, we review six cases of DFSP which were characterized by skin lesions in various parts of the body. Patients were from 26 to 51 years old; four were Asian men and two were Asian women. Wide surgical excision was performed for all these patients and no extra treatment was considered. Samples were studied by hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) tests. Only one of our patients experienced recurrence after the initial surgery.
conclusionDetermining the best surgical method is still a dilemma in the treatment of DFSP lesions. There are numerous studies to prove the efficacy of various surgical interventions. Although DFSP is not commonly known as a malignant skin lesion, delay in treatment will have a catastrophic impact on patients' lives. Thus, applying an in-time surgical method (wide local excision in our cases) in treating DFSP is crucial in preventing recurrence as well as decreasing the morbidity burden of DFSP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.